Ayabudge LLC - Aug 17, 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
10%+ Owner
Signature
/s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Aug 17, 2023
Transactions value $
-$6,378,837
Form type
4
Date filed
8/21/2023, 06:07 PM
Previous filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$2.1M -570K -5.71% $3.68 9.42M Aug 17, 2023 Direct F1, F2
transaction HUMA Common Stock Sale -$2.24M -627K -6.66% $3.57 8.79M Aug 18, 2023 Direct F1, F3
transaction HUMA Common Stock Sale -$2.04M -602K -6.85% $3.39 8.19M Aug 21, 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ayabudge LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Between August 17, 2023 and August 21, 2023, the Reporting Person sold 1,799,596 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.
F2 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.50 to $4.13. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.50 to $3.75. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.22 to $3.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.